Sino Biopharmaceutical Ltd (SBHMY)
7.20
0.00 (0.00%)
USD |
OTCM |
May 22, 16:00
Sino Biopharmaceutical Total Assets (Quarterly): 8.973B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.973B |
| June 30, 2023 | 9.049B |
| June 30, 2023 | 9.049B |
| December 31, 2022 | 9.286B |
| June 30, 2022 | 9.689B |
| June 30, 2022 | 9.689B |
| June 30, 2021 | 8.694B |
| June 30, 2021 | 8.694B |
| March 31, 2021 | 7.468B |
| December 31, 2020 | 7.226B |
| September 30, 2020 | 9.698B |
| June 30, 2020 | 9.639B |
| June 30, 2020 | 9.639B |
| March 31, 2020 | 9.372B |
| December 31, 2019 | 5.362B |
| September 30, 2019 | 7.548B |
| June 30, 2019 | 7.764B |
| March 31, 2019 | 7.662B |
| December 31, 2018 | 4.220B |
| September 30, 2018 | 5.423B |
| June 30, 2018 | 5.278B |
| March 31, 2018 | 5.487B |
| December 31, 2017 | 3.207B |
| September 30, 2017 | 3.088B |
| June 30, 2017 | 2.889B |
| Date | Value |
|---|---|
| March 31, 2017 | 2.888B |
| December 31, 2016 | 2.647B |
| September 30, 2016 | 2.655B |
| June 30, 2016 | 2.364B |
| March 31, 2016 | 2.338B |
| December 31, 2015 | 2.126B |
| September 30, 2015 | 2.255B |
| June 30, 2015 | 2.168B |
| March 31, 2015 | 1.992B |
| December 31, 2014 | 1.826B |
| September 30, 2014 | 1.753B |
| June 30, 2014 | 1.675B |
| March 31, 2014 | 1.422B |
| December 31, 2013 | 1.285B |
| September 30, 2013 | 1.249B |
| June 30, 2013 | 1.173B |
| March 31, 2013 | 1.106B |
| December 31, 2012 | 993.45M |
| September 30, 2012 | 1.021B |
| June 30, 2012 | 928.70M |
| December 31, 2011 | 793.95M |
| September 30, 2011 | 822.83M |
| June 30, 2011 | 822.91M |
| March 31, 2011 | 751.42M |
| June 30, 2010 | 685.20M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
5.362B
Minimum
Dec 2019
9.698B
Maximum
Sep 2020
8.638B
Average
9.049B
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Global Pharmatech Inc | -- |
| HUTCHMED (China) Ltd | 1.280B |
| Pharmaron Beijing Co Ltd | 3.058B |
| Regencell Bioscience Holdings Ltd | 12.62M |
| Prenetics Global Ltd | 254.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.588B |
| Shareholders Equity (Quarterly) | 4.299B |
| Debt to Equity Ratio | 0.4007 |
| Current Ratio | 1.053 |
| Net Debt Paydown Yield | 0.04% |